Delisting risk
IMNN · NASDAQ · Biotechnology

Imunon (IMNN)

Developing localized DNA immunotherapy for advanced ovarian cancer.

$1.69
Pre-market+0.11 (+7.30%)
At close$1.58(−1.56%)

Breakdown13F · 13D/G · Form 4

Institutions18 holders · as of Mar 31, 202611.98%503.6K shares
Insiders10 holders · as of Sep 1, 20267.25%304.8K shares
Otherremainder80.77%3.39M shares

4.20M company shares as of Aug 21, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Two share counts disagree (5.61M in the company's Sep 3, 2026 report, 4.20M elsewhere); stakes use the report.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Armistice Capital, LLCInstitution
8.29%348,33013Fas of Mar 31, 2026
Stacy LindborgInsiderdirector, officer: President and CEO
2.38%100,076Form 4filed Sep 1, 2026
Michael H. TardugnoInsiderdirector, officer: Executive Chairman of Board
2.14%89,875Form 4filed Sep 1, 2026
Vanguard Capital Management LLCInstitution
1.14%48,05613Fas of Mar 31, 2026
Douglas Vincent FallerInsiderofficer: Chief Medical Officer
0.88%37,077Form 4filed Sep 1, 2026
Riverview Capital Advisers, LLCInstitution
0.82%34,36413Fas of Mar 31, 2026
Geode Capital Management, LLCInstitution
0.79%33,21113Fas of Mar 31, 2026
James E. DentzerInsiderdirector
0.52%21,897Form 4filed Aug 4, 2026
Frederick J. FritzInsiderdirector
0.50%21,031Form 4filed Aug 4, 2026
Donald P. BraunInsiderdirector
0.37%15,499Form 4filed Aug 4, 2026
Christine A. PellizzariInsiderdirector
0.36%15,076Form 4filed Aug 4, 2026
Vanguard Fiduciary Trust CoInstitution
0.32%13,26913Fas of Mar 31, 2026
HRT Financial LPInstitution
0.29%12,05513Fas of Mar 31, 2026
BlackRock, Inc.Institution
0.11%4,46413Fas of Mar 31, 2026
Wells Fargo & Company/MNInstitution
0.08%3,34213Fas of Mar 31, 2026
Morgan StanleyInstitution
0.07%3,03513Fas of Mar 31, 2026
Susan EylwardInsiderofficer: General Counsel and Corp Sec
0.07%2,896Form 4filed Sep 1, 2026
Tower Research Capital LLC (TRC)Institution
0.04%1,86613Fas of Mar 31, 2026
Kimberly BraggInsiderofficer: CFO
0.03%1,360Form 4filed Jun 17, 2025
Sbi Securities Co., Ltd.Institution
0.02%1,02713Fas of Mar 31, 2026
UBS Group AGInstitution
0.01%57513Fas of Mar 31, 2026
Jeffrey Wayne ChurchInsiderofficer: CFO
0.00%26Form 4filed Jan 20, 2026
Group One Trading, L.P.Institution
0.00%613Fas of Mar 31, 2026
Federation Des Caisses Desjardins du QuebecInstitution
0.00%513Fas of Mar 31, 2026
Advisor Group Holdings, Inc.Institution
0.00%213Fas of Mar 31, 2026

13F — a manager's quarterly holdings · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

18 holders · 503.6K shares · 3 new positions · 9 increased · 3 reduced · 4 closed

HolderShares% outstandingChg q/qFiled
Armistice Capital, LLC348.3K8.29%+81.4KMay 15, 2026
Vanguard Capital Management LLC48.1K1.14%+48.1KnewMay 15, 2026
Riverview Capital Advisers, LLC34.4K0.82%0May 14, 2026
Geode Capital Management, LLC33.2K0.79%+12.0KMay 15, 2026
Vanguard Fiduciary Trust Co13.3K0.32%+13.3KnewMay 8, 2026
HRT Financial LP12.1K0.29%+12.1KnewMay 14, 2026
BlackRock, Inc.4.5K0.11%0May 13, 2026
Wells Fargo & Company/MN3.3K0.08%−96Jul 8, 2026

Ownership statements13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Armistice Capital, LLC9.99%396.7K13GMay 15, 2026
Opportunity Master Fund, SPC – Segregated Master Portfolio Bincl. Capital LLC, Khatri9.90%13GNov 14, 2024

Insider tradesForm 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Aug 31, 2026
Susan Eylwardofficer: General Counsel and Corp Sec
Sale2,525$1.562,896
Aug 17, 2026
Susan Eylwardofficer: General Counsel and Corp Sec
Sale2,449$1.632,896
Aug 3, 2026
Susan Eylwardofficer: General Counsel and Corp Sec
Sale2,541$1.572,896
Jul 20, 2026
Susan Eylwardofficer: General Counsel and Corp Sec
Sale2,150$1.782,896
Jul 6, 2026
Susan Eylwardofficer: General Counsel and Corp Sec
Sale920$1.882,896
Jun 29, 2026
Susan Eylwardofficer: General Counsel and Corp Sec
Sale11,800$1.752,896

CongressHouse and Senate disclosures

Not reported.